ABVC BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Abvc Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Abvc Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 12.4M shares, a 206% increase year-over-year.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.34M shares, a 36.9% increase from 2022.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3.17M shares, a 87.4% decline from 2021.
  • Abvc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.1M shares, a 27.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 12.4M +8.35M +206% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 11.3M +8.01M +242% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 9.74M +6.43M +194% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 4.34M +1.17M +36.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 4.06M +797K +24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 3.31M +178K +5.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 3.31M -26.4M -88.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 3.17M -21.9M -87.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 3.26M -23.6M -87.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 3.13M -21.3M -87.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 29.7M +5.26M +21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 25.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 26.9M +7.39M +37.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 24.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 24.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 19.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2019 17.4M +5.81M +50.1% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 15M +3.37M +29% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-28
Q4 2018 214M +137K +0.06% Oct 1, 2018 Dec 31, 2018 10-K 2019-04-15
Q3 2018 214M +180K +0.08% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 11.6M -202M -94.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 11.6M -200M -94.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 214M +2.93M +1.39% Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 214M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 214M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 212M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 211M +46.9M +28.6% Oct 1, 2016 Dec 31, 2016 10-Q/A 2018-03-19
Q4 2015 164M +109M +200% Oct 1, 2015 Dec 31, 2015 10-Q/A 2018-03-19
Q3 2015 161M Jul 21, 2015 Sep 30, 2015 10-K/A 2017-02-22
Q4 2014 54.6M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-23
Q2 2012 28.9M +18.3M +171% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-08-20
Q1 2012 16.3M +6.12M +60% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-15
Q4 2011 16.1M +9.22M +133% Oct 1, 2011 Dec 31, 2011 10-Q 2012-02-21
Q3 2011 9.74M Jul 1, 2011 Sep 30, 2011 10-K/A 2011-12-28
Q2 2011 10.7M +4.08M +61.9% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-20
Q1 2011 10.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 6.91M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q2 2010 6.58M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.